Aug 2026
Targeting the PLEC/TPM4 cytoskeletal axis: DT-13 inhibits colorectal cancer metastasis through direct binding to PLEC and inactivation of Akt/ERK signaling.
DT-13 exerts anti-metastatic effects in CRC by disrupting the PLEC/TPM4 cytoskeletal scaffold and suppressing the epithelial-mesenchymal transition process, highlighting the clinical potential of DT-13 as a safer therapeutic alternative for patients with metastatic CRC.
Jing-Yu Feng, Jing-Ling Yang, Rui Zhang et al.
· Phytomedicine · 0 citations